Free Trial

Sensus Healthcare (SRTS) News Today

Sensus Healthcare logo
$7.64 +0.35 (+4.80%)
(As of 11/15/2024 ET)
Sensus Healthcare price target raised to $14 from $12 at Maxim
Sensus Healthcare Reports Strong Q3 2024 Growth
Roth MKM Keeps Their Buy Rating on Sensus Healthcare (SRTS)
Sensus Healthcare, Inc. stock logo
Maxim Group Forecasts Strong Price Appreciation for Sensus Healthcare (NASDAQ:SRTS) Stock
Maxim Group increased their price objective on Sensus Healthcare from $12.00 to $14.00 and gave the company a "buy" rating in a report on Friday.
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (SRTS) Scheduled to Post Quarterly Earnings on Thursday
Sensus Healthcare (NASDAQ:SRTS) will be releasing earnings after the market closes on Thursday, November 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589487)
Sensus Healthcare, Inc. stock logo
Dimensional Fund Advisors LP Grows Holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS)
Dimensional Fund Advisors LP grew its stake in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 128.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 166,590 shares of the company's stock after acquiring an additional 93,511 shares during the p
Sensus Healthcare, Inc. stock logo
Renaissance Technologies LLC Increases Holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS)
Renaissance Technologies LLC lifted its position in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 34.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 391,534 shares of the company's stock after purchasing an additional 100,294 shares durin
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (NASDAQ:SRTS) Trading Up 5.1%
Sensus Healthcare (NASDAQ:SRTS) Trading Up 5.1%
Sensus Healthcare, Inc. stock logo
Roth Capital Comments on Sensus Healthcare, Inc.'s FY2024 Earnings (NASDAQ:SRTS)
Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Stock analysts at Roth Capital increased their FY2024 earnings per share (EPS) estimates for shares of Sensus Healthcare in a research note issued to investors on Friday, August 9th. Roth Capital analyst J. Wittes now forecasts that the compan
Sensus Healthcare earnings: here's what Wall Street expects
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (SRTS) to Release Earnings on Thursday
Sensus Healthcare (NASDAQ:SRTS) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=613354)
Sensus Healthcare Inc (SRTS)
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (NASDAQ:SRTS) Lifted to Strong-Buy at Roth Capital
Roth Capital raised shares of Sensus Healthcare to a "strong-buy" rating in a research note on Friday.
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (NASDAQ:SRTS) Stock Price Passes Below 50-Day Moving Average of $5.13
Sensus Healthcare (NASDAQ:SRTS) Stock Crosses Below 50-Day Moving Average of $5.13
Sensus Healthcare, Inc. stock logo
Short Interest in Sensus Healthcare, Inc. (NASDAQ:SRTS) Expands By 1,311.0%
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 437,400 shares, an increase of 1,311.0% from the April 30th total of 31,000 shares. Approximately 3.3% of the shares of the stock are sold short. Based on an average trading volume of 513,200 shares, the short-interest ratio is currently 0.9 days.
Sensus Healthcare, Inc. stock logo
Sensus Healthcare, Inc. (NASDAQ:SRTS) Director Sells $28,399.35 in Stock
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) Director John Heinrich sold 4,773 shares of Sensus Healthcare stock in a transaction on Friday, May 17th. The shares were sold at an average price of $5.95, for a total value of $28,399.35. Following the completion of the transaction, the director now owns 75,167 shares in the company, valued at approximately $447,243.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Sensus Healthcare, Inc. stock logo
Research Analysts Offer Predictions for Sensus Healthcare, Inc.'s Q2 2024 Earnings (NASDAQ:SRTS)
Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Stock analysts at HC Wainwright issued their Q2 2024 earnings estimates for Sensus Healthcare in a research note issued on Monday, May 13th. HC Wainwright analyst Y. Chen expects that the company will post earnings per share of $0.02 for the q
Sensus Healthcare, Inc. stock logo
HC Wainwright Equities Analysts Lift Earnings Estimates for Sensus Healthcare, Inc. (NASDAQ:SRTS)
Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Equities research analysts at HC Wainwright upped their Q4 2024 earnings per share (EPS) estimates for Sensus Healthcare in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst Y. Chen now forecasts that
Sensus Healthcare, Inc. stock logo
HC Wainwright Increases Sensus Healthcare (NASDAQ:SRTS) Price Target to $10.00
HC Wainwright upped their target price on Sensus Healthcare from $8.00 to $10.00 and gave the stock a "buy" rating in a research note on Monday.
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (NASDAQ:SRTS) Issues Quarterly Earnings Results, Beats Estimates By $0.18 EPS
Sensus Healthcare (NASDAQ:SRTS - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.18. Sensus Healthcare had a return on equity of 1.04% and a net margin of 1.99%. The company had revenue of $10.66 million for the quarter, compared to the consensus estimate of $4.33 million. During the same quarter in the previous year, the business earned ($0.12) EPS.
Sensus Healthcare, Inc. stock logo
Sensus Healthcare (NASDAQ:SRTS) Given New $10.00 Price Target at Maxim Group
Maxim Group raised their target price on shares of Sensus Healthcare from $7.00 to $10.00 and gave the company a "buy" rating in a report on Friday.
Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

SRTS Media Mentions By Week

SRTS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRTS
News Sentiment

0.82

0.56

Average
Medical
News Sentiment

SRTS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRTS Articles
This Week

13

2

SRTS Articles
Average Week

Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SRTS) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners